• Accueil
• depression
• Depression And Alzheimer's Treatments At A Crossroads : Short Wave

Depression And Alzheimer's Treatments At A Crossroads : Short Wave

4.8 (626) · € 21.00 · En Stock

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem. As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

IJMS, Free Full-Text

Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease - Sukoff Rizzo - 2023 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library

Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease - Sukoff Rizzo - 2023 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library

IJMS, Free Full-Text

MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy - Vafadari - 2016 - Journal of Neurochemistry - Wiley Online Library

Selected Neurology Publications - 2021

The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease: Molecular Therapy

The role of adenosine A2A receptors in Alzheimer's disease and tauopathies - ScienceDirect

Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?

Frontiers Local Sleep and Alzheimer's Disease Pathophysiology

Music Therapy Today WFMT online journal Vol. 18, No. 1 by World Federation of Music Therapy - Issuu

Depression And Alzheimer's Treatments At A Crossroads : Short Wave : NPR

Pharmaceutics, Free Full-Text